Singapore markets closed

Relay Therapeutics, Inc. (RLAY)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.95-0.16 (-2.70%)
As of 03:01PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
25,546
25,546
1,381
3,029
82,654
Operating expenses
Research development
330,018
330,018
246,355
172,650
99,862
Selling general and administrative
74,950
74,950
65,978
57,386
38,588
Total operating expenses
404,968
404,968
312,333
230,036
138,450
Operating income or loss
-379,422
-379,422
-310,952
-227,007
-55,796
Total other income/expenses net
6,404
6,404
11,657
-137,695
-16
Income before tax
-341,973
-341,973
-290,509
-363,872
-52,412
Income from continuing operations
-341,973
-341,973
-290,509
-363,872
-52,412
Net income
-341,973
-341,973
-290,509
-363,872
-52,412
Net income available to common shareholders
-341,973
-341,973
-290,509
-363,872
-230,201
Basic EPS
-2.67
-
-2.59
-3.82
-5.40
Diluted EPS
-2.67
-
-2.59
-3.82
-5.40
Basic average shares
121,648
-
112,234
95,137
42,620
Diluted average shares
121,648
-
112,234
95,137
42,620